- 期刊
Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis
延伸閱讀
- Fernández, O. (2012). Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis. Journal of Central Nervous System Disease, (), 117-133. https://doi.org/10.4137/JCNSD.S8755
- Khoshknab, M. F., Ghafari, S., Nourozi, K., & Mohammadi, E. (2014). Confronting the Diagnosis of Multiple Sclerosis: A Qualitative Study of Patient Experiences. The Journal of Nursing Research, 22(4), 275-282. https://doi.org/10.1097/jnr.0000000000000058
- Baumstarck, K., Boyer, L., Boucekine, M., Michel, P., Pelletier, J., & Auquier, P. (2013). Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge. Multiple Sclerosis International, 2013(), 155-162. https://doi.org/10.1155/2013/524894
- Kanekar, N., & Aruin, A. S. (2013). The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple Sclerosis. Multiple Sclerosis International, 2013(), 46-55. https://doi.org/10.1155/2013/190162
- Dimisianos, N., Rodi, M., Kalavrizioti, D., Georgiou, V., Papathanasopoulos, P., & Mouzaki, A. (2014). Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis. Multiple Sclerosis International, (2014), 84-91. https://doi.org/10.1155/2014/436764